Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Immunity|December 23, 2022
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinomaRui-Qi Wu, Xiang-Ming Lao, Dong-Ping Chen, et al.
Translational Oncology|January 7, 2026
Induction chemotherapy with nedaplatin, docetaxel and 5-fluorouracil followed by concurrent nedaplatin and radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A single arm, open label, phase II clinical trialFang-Zheng Chen, Ying Deng, Wen-Jing Yin, et al.
Cancer Research|July 8, 2022
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular CarcinomaJun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu, et al.
Plos One|April 16, 2011
Scientific publications in nephrology and urology journals from Chinese authors in East Asia: a 10-year survey of the literatureJing Xu, Zhi-Guo Mao, Mei Kong, et al.
The Journal of Clinical Investigation|April 2, 2026
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinomaJiong-Liang Wang, Jun-Cheng Wang, Yangxun Pan, et al.
JAMA Network Open|December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical TrialQing-Nan Tang, Li-Ting Liu, Bin Qi, et al.
Clinical Science (London, England : 1979)|November 18, 2015
Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effectorJing Xu, Pei-Xue Li, Jun Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2017
Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatmentXiong Zou, Rui You, Huai Liu, et al.
Journal of Cancer Research and Therapeutics|October 7, 2022
Chinese expert consensus on the nursing management of the totally implantable venous access deviceYin Xu, Xiao-Yan Fei, You-Hua Xue, et al.
The Lancet. Oncology|June 8, 2023
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialLi-Ting Liu, Huai Liu, Ying Huang, et al.
Pageof 8